Selective regional alterations in the content or distribution of neuronal and glial cytoskeletal proteins in brain of rats chronically exposed to 2,5-hexanedione

Abstract

Hexane is used in many industrial processes and induces neurotoxic effects in the central and peripheral nervous system. Hexane is metabolized to 2,5-hexanedione, which is the neurotoxic agent. Continued exposure to hexane or 2,5-hexanedione results in loss of sensorial and motor function in arms and legs and to alterations in axonal neurofilament proteins. The effects of 2,5-hexanedione on different cytoskeletal proteins in different brain areas have not been studied in detail. The aim of this work was to study the effects of chronic exposure of rats to 2,5-hexanedione (1% in the drinking water) on tubulin, neurofilament NF-L, microtubule-associated protein MAP-2, and on glial fibrillary acidic protein (GFAP), in cerebellum, hippocampus and cerebral cortex. The amount of each protein was determined by immunoblotting and its distribution was analysed by immunohistochemistry. The results obtained show a regional selectivity in the 2,5-hexanedione effects on cytoskeletal proteins. NF-L content decreased in all brain areas. MAP-2 decreased in cerebellum and hippocampus and tubulin decreased only in cerebellum. GFAP decreased only in cerebral cortex, but its distribution was altered in cerebellum, with increased content in the granular layer and decreased content in the molecular layer. The area most affected was the cerebellum, where all the proteins analysed were altered. These cytoskeletal proteins alterations may impair the transfer of information involved in the regulation by the cerebellum of motor function and contribute to the altered motor performance in rats exposed to 2,5-hexanedione and humans exposed to hexane.

Keywords

GFAP 2,5-hexanedione MAP-2 neurofilament-L neurotoxicity tubulin

Get full access to this article

View all access options for this article.

References

Abou-Donia, M. B. , Lapadula, D. M. and Suwita, E. 1988: Cytoskeletal proteins as targets for organophosphorus compounds and aliphatic hexacarbon-induced neurotoxi-city. Toxicology 49, 469-477.

Boekelheide, K. 1988: Rat testis during 2,5-hexanedione intoxication and recovery. Toxicology and Applied Pharmacology 92, 28-33.

Chiu, F. C. , Opanashuk, L. A. , He, D. K. et al. 2000: g-Diketone peripheral neuropathy. II Neurofilament subunit content. Toxicology and Applied Pharmacology 165, 141-147.

Couri, D. , Abdel-Rahman, M. S. and Hetland, L. B. 1978: Biotransformation of n-hexane and methyl n-butyl ketone in guinea pigs and mice. American Industrial Hygiene Association Journal 39, 295-300.

DeCaprio, A. P. 1985: Molecular mechanism of diketone neurotoxicity. Chemico-Biological Interactions 54, 257-270.

DeCaprio, A. P. and O’Neill, E. A. 1985: Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure. Toxicology and Applied Pharmacology 78, 235-247.

DeCaprio, A. P. and Weber, P. 1980: In vitro studies on the amino group reactivity of a neurotoxic hexacarbon solvent. Pharmacologist 22, 222-222.

DeCaprio, A. P. and Weber, P. 1981: Conversion of lysine o-amino groups to substituted pyrrole derivatives by 2,5- hexanedione: a possible mechanism of protein binding. Toxicology 1, 134-134.

DeCaprio, A. P. , Olajos, E. J. and Weber, P. 1982: Covalent binding of a neurotoxic n-hexane metabolite: Conversion of primary amines to substituted pyrrole adducts by 2,5- hexanedione. Toxicology and Applied Pharmacology 65, 440-450.

10.

DeCaprio, A. P. , Strominger, N. L. and Weber, P. 1983: Neurotoxicity and protein binding of 2,5-hexanedione in the hen. Toxicology and Applied Pharmacology 68, 297-307.

11.

Felipo, V. , Miñana, M. D. , Azorin, I. et al. 1988: Induction of rat brain tubulin following ammonium ingestion. Journal of Neurochemistry 51, 1041-1045.

12.

Fink, B. R. , Byers, M. R. and Middaugh, M. E. 1973: Dynamics of colchicine effects on rapid axonal transport and axonal morphology. Brain Research 56, 299-311.

13.

Hall, E. S. , Hall, S. J. and Boekelheide, K. 1995: 2,5-Hexane-dione exposure alters microtubule motor distribution in adult rats testis. Fundamental and Applied Toxicology 24, 173-182.

14.

Hernandez-Viadel, M. L. , Montoliu, C. , Monfort, P. et al. 2003: Chronic exposure to 2,5-hexanedione impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in rat brain in vivo. Journal of Neurochemistry 42, 525-533.

15.

Herskowitz, A. , Ishii, N. and Schaumburg, H. 1971: n-Hexane neuropathy: a syndrome occurring as a result of industrial exposure. New England Journal of Medicine 285, 82-85.

16.

Karlsson, J. E. , Rosengren, L. E. and Haglid, K. G. 1991: Quantitative and qualitative alterations of neural and glial intermediate filaments in rat nervous system after exposure to 2,5-hexanedione. Journal of Neurochemistry 57, 1437-1444.

17.

Komiya, Y. and Kurokawa, M. 1980: Preferential blockade of the tubulin transport by colchicine. Brain Research 190, 505-516.

18.

Krasavage, W. J. , O’Donoghue, J. L. , DiVincenzo, G. D. et al. 1980: The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. Toxicology and Applied Pharmacology 52, 433-441.

19.

Lapadula, D. M. , Suwita, E. and Abou-Donia, M. B. 1988: Evidence for multiple mechanisms responsible for 2,5- hexanedione-induced neuropathy. Brain Research 458, 123-131.

20.

Lee, M. K. and Cleveland, D. W. 1994: Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease. Current Opinion in Cell Biology 6, 34-40.

21.

Lehning, E. J. , Jortner, B. S. , Fox, J. H. et al. 2000: Diketone peripheral neuropathy. I. Quantitative morphometric analyses of axonal atrophy and swelling. Toxicology and Applied Pharmacology 165, 127-140.

22.

Monaco, S. , Autilio-Gambetti, L. , Zabel, D. et al. 1985: Giant axonal neuropathy: acceleration of neurofilament transport in optic axons. Proceedings of the National Academy of Sciences USA 82, 920-924.

23.

Muma, N. A. and Hoffman, P. N. 1993: Neurofilaments are intrinsic determinants of axonal caliber. Micron 24, 677-678.

24.

Opanashuk, L. A. , He, D. K. , Lehning, E. J. et al. 2001: g-Diketone peripheral neuropathy. III Neurofilament gene expression. Neurotoxicology 22, 215-220.

25.

Rakic, P. 1985: Mechanism of neuronal migration in developing cerebellar cortex. In Edelman, G. M. , Gall, W. E. and Cowan, W. M. , editors, Molecular basis of neural development. New York, 139-160.

26.

Rakic, P. and Sidman, R. L. 1973: Weaver mutant mouse cerebellum: defective neuronal migration secondary to abnormality of Bergmann glia. Proceedings of the National Academy of Sciences USA 70, 240-244.

27.

Sakata-Haga, H. , Sawada, K. , Hisano, S. et al. 2001: Abnormalities of cerebellar foliation in rats prenatally exposed to ethanol. Acta Neuropathologica 102, 36-40.

28.

Spencer, P. S. and Schaumburg, H. 1977: Ultrastructuralstudies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. Journal of Neuropathology and Experimental Neurology 36, 276-299.

29.

Spencer, P. S. , Bischoff, M. C. and Schaumburg, H. H. 1978: On the specific molecular configuration of neurotoxic aliphatic hexacarbon compounds causing central-peripheral distal axonopathy. Toxicology and Applied Pharmacology 44, 17-28.

30.

Spencer, P. S. , Schaumburg, H. H. , Sabri, M. I. et al. 1980: The enlarging view of hexacarbon neurotoxicity. CRC Critical Reviews in Toxicology 7, 279-356.

31.

Yamada, S. 1964: An occurrence of polyneuritis by n-hexane in the polyethylene laminating plants. Japanese Journal of Industrial Health 6, 192-192.